History
The Vision Behind the Evolution: Bridging Healthcare’s Capital Gap
The transition from CryptoCyte on the public Ethereum blockchain to the native NMD™ unit on the permissioned NEXAS™ Hyperledger Fabric network was not an emergency pivot—it was the intentional execution of an architecture designed from day one to solve a systemic crisis in American healthcare.
The Crisis: The Healthcare Funding Gap
Across the United States, rural and safety-net healthcare facilities face an existential financial crisis. Over 40 percent of rural hospitals operate at a negative operating margin, hundreds have closed or converted to non-inpatient models over the past two decades, and dozens more discontinue vital services—like labor and delivery or chemotherapy—every year.
This financial strain creates a severe technology and capital gap. Outdated infrastructure, un-upgraded electronic health records, and a lack of predictive AI tools leave rural facilities vulnerable to operational failures and cybersecurity breaches. Crucial capital purchases, such as a modern MRI machine or updated delivery transport vehicles, are routinely out of reach for institutions operating on razor-thin margins. Traditional relief efforts, while helpful, often offer one-time technology injections without funding ongoing maintenance, leaving the most vulnerable facilities stranded.
The Innovation: Non-Participatory Macroeconomic Valuation
To solve this funding gap without adding institutional debt or relying on discretionary cash, our framework introduced a new asset class: the Non-Participatory Externally Valued Fungible Token (NEXFT™).
Instead of deriving value from market speculation, high-frequency trading, or network staking, 1 unit of the asset is strictly pegged to the annual, macroeconomically modeled per-capita economic output of a practicing U.S. physician. Calculated using third-party IMPLAN input-output modeling and verified macroeconomic data (incorporating BLS Producer Price Indexes, CMS National Health Expenditures, and FSMB licensure data), the asset’s value reflects real-world productivity ($3.16M in 2015 baseline data, extrapolating to ~$5.21M by 2025).
Because the value tracks an external, pre-existing economic reality independent of promoter efforts or network trading volume, the asset functions as a non-speculative commodity settlement instrument rather than an investment contract.
The Path: Why the Evolution Took Place
1. The Public Ethereum Phase (CryptoCyte) The initial deployment of CryptoCyte as an ERC-20 token on Ethereum served as a proof-of-concept. It established the legal, foundational, and cryptographic footprint of the asset. However, public blockchains inherently carry barriers that prevent enterprise healthcare adoption:
- Volatile gas fees and unpredictable transaction overhead.
- Competitive anti-trust exposure caused by globally searchable, transparent ledger entries.
- Risk of market-driven price discovery and speculative volatility.
- Vulnerability to irreversible wallet misdirection or private-key loss without administrative recourse.
1b. The Strategic Rejection of Public Exchange Listings
During this proof-of-concept phase, formal opportunities emerged to list CryptoCyte on centralized public digital asset exchanges, including formal listing agreements presented by international trading platforms such as Coinstore (Veraxa Ltd.).
However, public exchange listing was deliberately rejected because it fundamentally conflicted with the core purpose of the asset:
- Public Listings Cannot Solve Public Chain Volatility: Placing CryptoCyte on an open order book subjects the token to speculative market price discovery, high-frequency trading, and retail volatility. This would decouple the unit from its strict macroeconomic peg to physician productivity, converting a stable B2B healthcare settlement tool into a speculative asset.
- Preservation of Non-Speculative Regulatory Status: Accepting centralized exchange terms—including mandatory market-making liquidity pools and public retail order books—risked blurring the line between a utility-driven settlement rail and a public investment contract.
- Incompatibility with Enterprise Privacy: Public exchange exposure does not resolve the anti-trust and commercial privacy risks associated with public ledger entries when healthcare providers and vendors standardize equipment pricing.
Recognizing that a public listing would exacerbate rather than solve the friction of public blockchains, leadership formally declined exchange deployment. This decision accelerated the pivot away from public ERC-20 infrastructure entirely and toward a fully private, permissioned architecture.
2. Corporate Unification & Non-Profit Governance To ensure complete legal purity and protect the public-benefit mission of the asset, Bolton-Strid LLC formally transferred 100% of administrative roles, token contracts, and operational balances to The Bolton-Strid Foundation Inc., a Montana state-recognized non-profit organization. The LLC was subsequently dissolved, creating an absolute legal separation. The Foundation acts as a non-profit custodian, distributing unit allocations to qualifying healthcare facilities at zero cost based on verified, documented capital needs.
3. The Enterprise Settlement Rail (NEXAS™ / NMD™) Migrating to a permissioned Hyperledger Fabric architecture fulfilled the original whitepaper’s vision of an enterprise-grade settlement network:
- Closed-Loop B2B Commerce: Healthcare entities (Layer 1) receive free allocations to purchase equipment from suppliers (Layer 2). Suppliers can spend units with other suppliers or spend them back into healthcare services.
- Built-in Velocity & Tax Efficiency: Receiving units creates an ordinary income event offset when spent within the same tax year on qualifying bonus-depreciable capital equipment. This tax structure incentivizes rapid circulation through the supply chain rather than passive holding.
- Enterprise Security & Privacy: Membership Service Providers (MSPs) enforce verified identities, high transaction throughput, zero gas fees, and private channels that protect commercial privacy.
Through this metamorphosis, CryptoCyte evolved from an experimental token into NMD™—the operational fuel of a permissioned network engineered to fund life-saving healthcare infrastructure across America.
Timeline
This timeline details the structural metamorphosis of our physician-indexed economic digital asset—tracing its origins from an experimental public ERC-20 token on Ethereum to its final institutional deployment as a permissioned, B2B settlement network built on Hyperledger Fabric.
Phase I: Structural Genesis & Legal Infrastructure
- January 20, 2025 – Corporate Formation: Bolton-Strid LLC is officially filed and registered with the Montana Secretary of State.
- February 15, 2025 – Original Token Deployment: The original CryptoCyte ERC-20 token contract is deployed on the public Ethereum mainnet and minted directly to the Bolton-Strid LLC corporate wallet.
- February 16, 2025 – Initial Allocation: A partial transfer of CryptoCyte tokens is executed from the LLC wallet to the personal wallet of Founder and CEO Dr. Jesse Alexander Galinski, MD, DHA.
- February 20, 2025 –State Nonprofit Entity Establishment: The Bolton-Strid Foundation Inc. is officially filed as a Montana state-recognized nonprofit organization, and its official digital wallet is generated.
- February 20, 2025 – Non-Profit Treasury Transfer: The remaining balance of the primary token allocation is transferred from Bolton-Strid LLC to the newly established Foundation wallet.
Phase II: Institutional Separation & Administrative Transfer
- September 13, 2025 – Complete Role Assignment: All administrative, minting, pausing, and upgrading smart contract permissions previously held by Bolton-Strid LLC are formally transferred to The Bolton-Strid Foundation Inc.
- Minter Role:
0xa0eb01128f70d289777bf33e2d72cbaf809950a8f44cdb6eef39d2bc1bcb8ffe - Pauser Role:
0x5a985c1996da82bd0df3f9daffb5340f124c45cbc63359184c2a7977dece2018 - Upgrader Role:
0x90e7277feece0f12c8ac3ffd15d1d0a4c0fc355766050845674460ad50ceb62f - Default Admin Role:
0x394592cfe158a2f649d2b73dd770cd670be15c0c0c77864feac79e96a590913b
- Minter Role:
- September 13, 2025 – Irrevocable Privileges Revocation: The Foundation executes transactions revoking all access and administrative permissions from Bolton-Strid LLC, eliminating any residual control or ownership by the LLC.
- Minter Revocation:
0x1d95c5835cle488e0cc3cf702b58b3d11d43c7e5dce538e7f8587ddd9c7dd84a - Pauser Revocation:
0x8f841fc3eab132a80851b92197cc1170d9edb9c8506131e44b36d6bf9722f672 - Upgrader Revocation:
0xac8260b57caebfe1d0df0f586bf27923d9016cf083f82a0978e12a0ab836d30f - Admin Revocation:
0xfbc1cf10c169ff97e3baf45025b2efd276389faee4ae822balf41265a7bf3e06
- Minter Revocation:
- September 13, 2025 – Final Treasury Clearance & Corporate Dissolution: All remaining operational gas funds (ETH, Sepolia ETH, USDC) are transferred to the Foundation, thee were de minimis values of USD $10 or less. Bolton-Strid LLC is administratively dissolved through the Montana Secretary of State, establishing a total legal separation. 100% of the asset remains unrealized with zero public circulation.
- October 6, 2025 – Memorandum Execution: Formal administrative memorandum signed by Dr. Jesse Galinski documenting the full audit trail and transaction hashes.
Phase III: Architectural Metamorphosis (Hyperledger Fabric Migration) – in Process
- Public-Chain Limitations Recognized: Public Layer-1 infrastructure introduces friction for enterprise adoption, including gas price volatility, public transaction transparency risks under anti-trust law, double-spend concerns, and speculative market price discovery.
- Transition to Enterprise Infrastructure: The decision is made to migrate the underlying asset logic from Ethereum ERC-20 to Hyperledger Fabric—a transition explicitly anticipated as platform-agnostic in the original project whitepaper.
- Rebranding to NMD™ / NEXAS™ Network: CryptoCyte transitions into the native settlement unit (NMD™) running on the NEXAS™ Hyperledger Fabric private network.
Phase IV: The Institutional Network Architecture
- Closed-Loop B2B Settlement: Rather than operating as a public speculative cryptocurrency, NMD™ operates as a B2B transactional rail bridging healthcare organizations (Layer 1) and equipment/service vendors (Layer 2).
- Decoupled State Engine: The ledger enforces complete separation between ownership, value, and supply. Transaction volume cannot alter asset value.
- Macroeconomic Indexing: 1 NMD™ unit value is anchored to the external per-capita macroeconomic output of a U.S. practicing physician calculated via IMPLAN modeling ($3.16M baseline in 2015, projected to $5M+ in 2026).
- Developer Rollover Model: Contractors building the Fabric architecture receive CryptoCyte tokens during development, which convert 1:1 into native NMD™ network units upon full network rollover.
Core Protocol Architectural Comparison
| Feature | Legacy CryptoCyte Model | Current NMD™ / NEXAS™ Model |
| Blockchain Protocol | Public Ethereum (ERC-20) | Permissioned Hyperledger Fabric |
| Governance Entity | Bolton-Strid LLC (Dissolved) | The Bolton-Strid Foundation Inc. (Nonprofit) |
| Primary Use Case | Public Asset / Demonstrative Implementation | Closed-Loop Healthcare Quality Improvement & Equipment Settlement |
| Value Mechanics | Externally Indexed (Public Exposure Risks) | Fixed Annual Re-indexing (Zero Speculative Volatility) |
| Access Control | Open Wallet Network | Enterprise MSPs / Verified Digital Identities |
| Tax Synergy | Open Crypto Taxation | Ordinary Income Offset via IRC Bonus Depreciation Realization |
Appendix A: Quantitative Macroeconomic Valuation Framework
The valuation engine anchors 1 NMD™ directly to the per-capita economic output of an active U.S. physician, derived through IMPLAN input-output matrix analysis. Based on baseline metrics ($3.16M per physician in 2015 baseline data, accounting for direct clinical revenue, indirect supply chain purchasing, and induced household spending), the model indexes against real-time updates from Bureau of Labor Statistics (BLS) Producer Price Indexes, CMS National Health Expenditure data, and state medical board licensing registries. This creates an auditable annual macro-rebalancing framework ($5.21M projected target for 2025) that updates once per year, totally independent of network transaction velocity.
Appendix B: Legacy Token Immobilization & Developer Rollover Protocol
Because the original Ethereum contract had minted tokens during the proof-of-concept phase, leadership executed a strict containment protocol. 100% of the asset remained unrealized with zero public circulation. To honor obligations to early technical contractors and system developers who held development allocations, a formal Rollover Model was established. Early development tokens were locked and slated for a seamless 1:1 swap into native NMD™ units upon the full launch of the Hyperledger Fabric mainnet, completely immobilizing the legacy Ethereum contract and preventing any rogue secondary market liquidity.
Appendix C: Irrevocable Fiduciary Covenants
To permanently safeguard the asset’s structural integrity against future internal or corporate manipulation, the Foundation instituted an absolute governance covenant within its operational framework. Built directly into the network’s administrative bylaws, this self-executing clause automatically and immediately removes any officer, director, or board member who attempts to introduce a motion, vote, or code alteration that modifies the 1:1 asset ratio pegged to physician macroeconomic output. This guarantees that the asset can never be artificially inflated, debased, or converted into a speculative instrument by future management.
Etherscan and GitHub of Original CryptoCyte Token
https://etherscan.io/token/0x9D106215616d7282A1f65Ea615517DDf9AD9a3Ed#tokenInfo